Articles by NK Mehra
Xenotransplantation and the future of medicine
The first successful pig-to-human heart transplant achieved through genetic engineering represents a step forward in solving the problem of organ shortage

Focus on double-dose vaccinations. Boosters can wait
India must singularly focus on vaccinating all of its 18-plus adult population by the end of the year and even include children above 12 years as early as possible. Booster doses can wait until the science demonstrates that they are needed

Updated on Aug 24, 2021 03:33 PM IST
A tale of two infections
The key to prevention of mucormycosis is prompt control of hyperglycemia, maintenance of hygiene, and judicious use of steroids; the key to treating it is early diagnosis for ameliorating morbidity and mortality

Updated on May 25, 2021 01:05 PM IST
How India can overcome the Covid-19 surge
While India has to successfully battle the second wave, it is important not to create panic, but stay calm. The surge will settle soon—but for that, a mix of scientific, administrative and behavioural changes are essential

Updated on Apr 09, 2021 07:02 AM IST
Reducing the cost of Covid-19 vaccines is desirable and possible
It is reasonable for the vaccine industry to price the vaccine at ₹60-70 per dose as against the existing ₹150 per dose. This would cover all costs, including capital loading for additional investments made for ramping up the manufacturing capacities

Published on Mar 24, 2021 07:07 PM IST
The scientific enquiry on Covid-19 immunity
There are five key takeaways from the immunology-focused studies that deserve mention. The data generated has been helpful in forecasting the outcome of the disease, and developing effective strategies to control Covid-19

Updated on Sep 21, 2020 06:44 PM IST
Covid-19: Decoding the global search for a vaccine
There is progress. But it is crucial to follow the best regulatory and ethical practices, even if it takes time

Updated on Aug 11, 2020 09:35 PM IST
Covid-19: The science behind India’s trajectory| Analysis
The predominantly asymptomatic course of the disease and limited number of critical cases merit more scrutiny

Updated on May 20, 2020 06:44 PM IST
Covid-19: India has done well till now, but lifting the lockdown is not advisable
It is critical to sustain the benefits of the lockdown and the inherent immunity that the population enjoys

Published on Apr 09, 2020 07:03 PM IST